These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25197918)

  • 1. Bilastine as a potential treatment in allergic rhinitis.
    Kowal K; DuBuske L
    Am J Rhinol Allergy; 2014; 28(4):312-6. PubMed ID: 25197918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.
    Jáuregui I; García-Lirio E; Soriano AM; Gamboa PM; Antépara I
    Expert Rev Clin Immunol; 2012 Jan; 8(1):33-41. PubMed ID: 22149338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.
    Bousquet J; Ansótegui I; Canonica GW; Zuberbier T; Baena-Cagnani CE; Bachert C; Cruz AA; González SN; Kuna P; Morais-Almeida M; Mullol J; Ryan DP; Sánchez-Borges M; Valiente R; Church MK
    Curr Med Res Opin; 2012 Jan; 28(1):131-9. PubMed ID: 22149770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bilastine upon nasal obstruction.
    Dávila I; Sastre J; Mullol J; Montoro J; Jáuregui I; Ferrer M; del Cuvillo A; Bartra J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():2-8. PubMed ID: 22185044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety profile of bilastine: 2nd generation H1-antihistamines.
    Scaglione F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1999-2005. PubMed ID: 23242729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilastine: a lifetime companion for the treatment of allergies.
    Church MK; Tiongco-Recto M; Ridolo E; Novák Z
    Curr Med Res Opin; 2020 Mar; 36(3):445-454. PubMed ID: 31612732
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of Bilastine in Allergic Rhinitis: A Narrative Review.
    Tiwaskar M; Vora A; Tewary K; Prakash A; Tripathi KK; Jain S; Ilambarati ; Pandit G; Singh BP
    J Assoc Physicians India; 2023 Nov; 71(11):58-61. PubMed ID: 38720498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How bilastine is used to treat allergic rhinitis and urticaria in children.
    Rodríguez Del Río P; Rodríguez Fernández F; Ballester Asensio E; Tortajada-Girbés M
    Immunotherapy; 2022 Jan; 14(1):77-89. PubMed ID: 34850647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilastine for the relief of allergy symptoms.
    Sádaba Díaz de Rada B; Azanza Perea JR; Gomez-Guiu Hormigos A
    Drugs Today (Barc); 2011 Apr; 47(4):251-62. PubMed ID: 21573249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria.
    Church MK
    Expert Opin Drug Saf; 2011 Sep; 10(5):779-93. PubMed ID: 21831011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria.
    Sologuren A; Viñas R; Cordón E; Riesgo SE; Del Mar Forés M; Senán MR; Fernández S; Labeaga L; Ruiz-Miján M
    Allergy Asthma Proc; 2018 Jul; 39(4):299-304. PubMed ID: 29559031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.
    Bachert C; Kuna P; Sanquer F; Ivan P; Dimitrov V; Gorina MM; van de Heyning P; Loureiro A;
    Allergy; 2009 Jan; 64(1):158-65. PubMed ID: 19132976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilastine safety in drivers who need antihistamines: new evidence from high-speed simulator driving test on allergic patients.
    Demonte A; Guanti MB; Liberati S; Biffi A; Fernando F; Fainello M; Pepe P
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):820-828. PubMed ID: 29461615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilastine: a new H
    Church MK; Labeaga L
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1447-1452. PubMed ID: 28467671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.
    Corcóstegui R; Labeaga L; Innerárity A; Berisa A; Orjales A
    Drugs R D; 2006; 7(4):219-31. PubMed ID: 16784247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilastine and quality of life.
    Jáuregui I; Bartra J; del Cuvillo A; Dávila I; Ferrer M; Montoro J; Mullol J; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():16-23. PubMed ID: 22185046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilastine: in allergic rhinitis and urticaria.
    Carter NJ
    Drugs; 2012 Jun; 72(9):1257-69. PubMed ID: 22686617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.
    Sastre J; Mullol J; Valero A; Valiente R;
    Curr Med Res Opin; 2012 Jan; 28(1):121-30. PubMed ID: 22077106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.